Lingyi Biotech Co., Ltd. is a leading company in the development of next generation AAV gene therapy (AAV2.0) drugs for monogenic genetic diseases. The company is committed to original innovation, with a focus on clinically urgent areas such as metabolism, the central nervous system, and ophthalmology. By leveraging key technologies, including genetic disease animal models, the company aims to provide patients with comprehensive solutions.
Company Details
- Employees
- 4
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.lingyimed.com
Lingyi Biotech Co., Ltd. Questions
Lingyi Biotech Co., Ltd.'s website is http://www.lingyimed.com
Lingyi Biotech Co., Ltd.'s LinkedIn profile is https://www.linkedin.com/company/lingyi-biotech-co-ltd
Lingyi Biotech Co., Ltd. has
4 employees.
View email and phone details for 4
employees at Lingyi Biotech Co., Ltd..
Lingyi Biotech Co., Ltd.'s industry is
Biotechnology Research
Lingyi Biotech Co., Ltd.'s top competitors are
Accuredit Therapeutics,
Boulder Peptide Foundation,
Velvet Therapeutics,
Cyberna,
Nodthera,
Gritgen Therapeutics,
Overland Pharmaceuticals,
北京清辉联诺生物科技有限责任公司-Unicet Biotech,
Kcas Bio,
Surrozen.
Lingyi Biotech Co., Ltd.'s categories are Biotechnology Research
Lingyi Biotech Co., Ltd.'s founding year is 2021
